Literature DB >> 23187988

Validating the difficult intravenous access clinical prediction rule.

Michael Brendan O'Neill1, Martina Dillane, Noor Fahitah Abu Hanipah.   

Abstract

OBJECTIVE: This study aimed to evaluate the difficult intravenous access (DIVA) score, a clinical prediction rule, which states that children with a score of 4 or more will have a 50% higher rate of a failed intravenous placement on the first attempt compared with the mean failure rate.
METHODS: This was a prospective cohort study in children 0 to 14 years, undergoing peripheral intravenous placement by doctors in the emergency department of a medium-sized general hospital. Before intravenous placement attempts, demographic data inclusive of age and DIVA score were recorded. A maximum of 3 attempts per doctor were allowed, after which a more senior doctor undertook subsequent attempts. The site of successful placement was recorded.
RESULTS: Five hundred children were enrolled. The male-female ratio was 1.3:1. One hundred thirty-three (26.6%) were less than 1 year, 103 (20.6%) were aged 1 to 2 years, and 264 (52.8%) were 3 years or older. One hundred ten children (22%) had a failed intravenous placement on the first attempt. Of the 151 children with a DIVA score of 4 or more, 57 (37.7%) had a failed intravenous placement, validating the clinical prediction rule. Only 5 subjects (1%) did not have intravenous placement after 6 attempts.
CONCLUSIONS: This study validates DIVA score and provides a simple tool that can enhance the accuracy of the information offered to parents as it relates to the success rates of intravenous placement in children.

Entities:  

Mesh:

Year:  2012        PMID: 23187988     DOI: 10.1097/PEC.0b013e3182768bc9

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  7 in total

1.  Development of a clinical prediction rule to improve peripheral intravenous cannulae first attempt success in the emergency department and reduce post insertion failure rates: the Vascular Access Decisions in the Emergency Room (VADER) study protocol.

Authors:  Peter J Carr; James C R Rippey; Marie L Cooke; Chrianna Bharat; Kevin Murray; Niall S Higgins; Aileen Foale; Claire M Rickard
Journal:  BMJ Open       Date:  2016-02-11       Impact factor: 2.692

2.  A clinical rule for the difficulty prediction on scalp intravenous access in infants (SIAI) from emergency room.

Authors:  Fengqin Wei; Weiyu Chen; Xiaoti Lin
Journal:  Sci Rep       Date:  2020-04-20       Impact factor: 4.379

3.  Difficult intravenous access as an independent predictor of delayed care and prolonged length of stay in the emergency department.

Authors:  Hamid Shokoohi; Michael A Loesche; Nicole M Duggan; Andrew S Liteplo; Calvin Huang; Ahad A Al Saud; Dustin McEvoy; Shan W Liu; Sayon Dutta
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-08-19

4.  Improving peripheral venous cannula insertion in children: a mixed methods study to develop the DIVA key.

Authors:  Jessica A Schults; Tricia M Kleidon; Victoria Gibson; Robert S Ware; Emily Monteagle; Rebecca Paterson; Karina Charles; Adam Keys; Craig A McBride; Steven McTaggart; Benjamin Lawton; Fiona Macfarlane; Chloe Sells; Claire M Rickard; Amanda J Ullman
Journal:  BMC Health Serv Res       Date:  2022-02-17       Impact factor: 2.655

5.  Vascular ultrasound in pediatrics: estimation of depth and diameter of jugular and femoral vessels.

Authors:  J M López Álvarez; O Pérez Quevedo; L Santana Cabrera; C Rodríguez Escot; J F Loro Ferrer; T Ramírez Lorenzo; J M Limiñana Cañal
Journal:  J Ultrasound       Date:  2017-11-14

6.  Towards a low-cost mobile subcutaneous vein detection solution using near-infrared spectroscopy.

Authors:  Simon Juric; Vojko Flis; Matjaz Debevc; Andreas Holzinger; Borut Zalik
Journal:  ScientificWorldJournal       Date:  2014-04-30

7.  Angiography in pediatric patients: Measurement and estimation of femoral vessel diameter.

Authors:  Xue-Qi Fang; Hao Zhang; Ji-Ming Zhou
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.